Onkologie 2020: 14(Suppl.F): 144-147 | DOI: 10.36290/xon.2020.083

Pembrolizumab in combination with radiotherapy in a patient with generalized melanoma

Ivana Krajsová
Dermatovenerologická klinika VFN a 1. LF UK, Praha

Immunotherapy with anti PD-1 antibodies is one of the fundamental treatment for melanoma and radiotherapy has been used for decades, especially in palliative care. Recent studies suggest that immunotherapy and radiotherapy can act synergistically and in some cases may have an abscopal effect. In our patient, we observed, when we combined pembrolizumab with radiotherapy for nodal metastases, a significant improvement in the overal condition, including stabilization of organ metastases.

Keywords: metastatic melanoma, immunotherapy, pembrolizumab, radiotherapy, synergistic efect.

Published: November 19, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krajsová I. Pembrolizumab in combination with radiotherapy in a patient with generalized melanoma. Onkologie. 2020;14(Suppl.F / Onkologické kazuistiky 5):144-147. doi: 10.36290/xon.2020.083.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Escorcia FE, Postow MA, Barker AC, et al. Radiotherapy and immune checkpoint blockade for melanoma: a promising combinatorial strategy in need of further investigation. Cancer J 2017; 23(1): 32-39. Go to original source... Go to PubMed...
    2. Filippi AR, Fava P, Badellino S, et al. Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiotherapy and Oncology, 2016; 120: 1-12. Go to original source... Go to PubMed...
    3. Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol 1975; 48: 863-866. Go to original source... Go to PubMed...
    4. Hiniker SM, Reddy AS, Maecker HT, et al. A prospective clinical trial combining radiation therapy with systemic immunotherapy in metastatic melanoma. Int J Radiat Oncol Biol Phys, 2016; 96(3): 578-588. Go to original source... Go to PubMed...
    5. Hamid O, Robert C, Daud A, et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol 2019; 30(4): 582-588. Go to original source... Go to PubMed...
    6. Sharabi AB, Lim M, DeWeese TL, et al. Radiation and checkpoint blockade immunotherapy:radiosensitisation and potential mechanism of synergy. Lancet Oncol, 2015; 16: 498-509. Go to original source... Go to PubMed...
    7. Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. The New Engl J Med, 2012; 366: 925-931. Go to original source... Go to PubMed...
    8. Abuodeh Y, Venkat P, Sungjune K. Systematic review of case reports on the abscopal effect. Curr Probl Cancer, 2016; 40: 25-37. Go to original source... Go to PubMed...
    9. Yip K, Melcher A, Larkin J, et al. Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial. Clinical Oncology 2018; 30: 201-203. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.